MedPath
HSA Approval

PALONOSETRON-AFT SOLUTION FOR INJECTION 0.25MG/5ML

SIN16959P

PALONOSETRON-AFT SOLUTION FOR INJECTION 0.25MG/5ML

PALONOSETRON-AFT SOLUTION FOR INJECTION 0.25MG/5ML

February 20, 2024

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

A04AA05

palonosetron

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

QILU PHARMACEUTICAL (HAINAN), CO., LTD.

Active Ingredients

PALONOSETRON HYDROCHLORIDE EQV PALONOSETRON

0.25mg/5ml

Palonosetron

Documents

Package Inserts

Palonosetron-AFT PI.pdf

Approved: February 20, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.